Indoleamine 2,3-dioxygenase (IDO) activity was stimulated by LPS in resident antigen-presenting cells and tumor cells, leading to the increased production of Kyn from tryptophan, which activated AHR and subsequently led to increased immune tolerance. The gene discussed is AHR; the disease is neoplasm.